BDO Wealth Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$1.9K Hold
5
﹤0.01% 861
2023
Q1
$2.4K Hold
5
﹤0.01% 889
2022
Q4
$2.1K Hold
5
﹤0.01% 868
2022
Q3
$2K Hold
5
﹤0.01% 914
2022
Q2
$2K Hold
5
﹤0.01% 886
2022
Q1
$3K Hold
5
﹤0.01% 876
2021
Q4
$4K Hold
5
﹤0.01% 845
2021
Q3
$4K Hold
5
﹤0.01% 851
2021
Q2
$3K Hold
5
﹤0.01% 930
2021
Q1
$3K Hold
5
﹤0.01% 916
2020
Q4
$3K Hold
5
﹤0.01% 695
2020
Q3
$3K Buy
+5
New +$2.53K ﹤0.01% 609

Other funds holding BIO

BDO Wealth Advisors's BIO Position: Q2 2023 in Review

BDO Wealth Advisors held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2023 at 5 shares worth $1.9K. The position accounts for ﹤0.01% of the portfolio, ranked #861.

BDO Wealth Advisors first reported a position in BIO in Q3 2020 and has held it in 12 quarters since. The position peaked at $4K in Q4 2021. 468 funds tracked by Wall St. Rank hold BIO as of Q2 2023.

  • BDO Wealth Advisors held 5 shares of Bio-Rad Laboratories Class A worth $1.9K as of Q2 2023.
  • BDO Wealth Advisors left its Bio-Rad Laboratories Class A share count unchanged in Q2 2023.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #861 holding.
  • BDO Wealth Advisors first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and has held it in 12 quarters since.
  • BDO Wealth Advisors's Bio-Rad Laboratories Class A position peaked at $4K in Q4 2021.
  • 468 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.